Welcome to LookChem.com Sign In|Join Free

CAS

  • or

27952-00-7

Post Buying Request

27952-00-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

27952-00-7 Usage

Description

(E)-2-(4-bromostyryl)pyridine, with the molecular formula C12H9BrN, is a chemical compound derived from pyridine. It features a bromine atom and a styryl group, which may contribute to its chemical and biological properties. (E)-2-(4-bromostyryl)pyridine holds potential for use in organic synthesis and pharmaceutical research, serving as an intermediate in the production of other chemicals or as a building block for more complex compounds.

Uses

Used in Organic Synthesis:
(E)-2-(4-bromostyryl)pyridine is used as an intermediate in the synthesis of various chemicals. Its unique structure, including the bromine and styryl groups, allows for further chemical reactions and modifications, making it a valuable component in creating a range of compounds.
Used in Pharmaceutical Research:
In the pharmaceutical industry, (E)-2-(4-bromostyryl)pyridine is used as a building block for the synthesis of more complex compounds with potential medicinal properties. Its structural features may contribute to the development of new drugs or drug candidates, particularly those targeting specific biological pathways or receptors.

Check Digit Verification of cas no

The CAS Registry Mumber 27952-00-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,7,9,5 and 2 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 27952-00:
(7*2)+(6*7)+(5*9)+(4*5)+(3*2)+(2*0)+(1*0)=127
127 % 10 = 7
So 27952-00-7 is a valid CAS Registry Number.

27952-00-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-(4-bromo-styryl)-pyridine

1.2 Other means of identification

Product number -
Other names 4'-Brom-α-stilbazol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:27952-00-7 SDS

27952-00-7Relevant articles and documents

A new insight into the push-pull effect of substituents via the stilbene-like model compounds

Cao, Chaotun,Cao, Chenzhong,Zeng, Zhao

, (2022/02/01)

In this paper, authors report on 1-pyridyl-2-arylethenes, 1-furyl-2-arylethylenes, 1,2-diphenylpropylenes and substituted cinnamyl anilines as stilbene-like model compounds to investigate the factors dominating the push-pull effect of substituents via usi

Borane-Catalyzed Chemoselective and Enantioselective Reduction of 2-Vinyl-Substituted Pyridines

Hu, Chen-Yu,Li, Xiang,Liang, Xin-Shen,Liu, Ning,Tian, Jun-Jie,Tu, Xian-Shuang,Wang, Xiao-Chen,Yang, Zhao-Ying

supporting information, p. 18452 - 18456 (2020/08/21)

Herein, we report that highly chemoselective and enantioselective reduction of 2-vinyl-substituted pyridines has been achieved for the first time. The reaction, which uses chiral spiro-bicyclic bisboranes as catalysts and HBpin and an acidic amide as reducing reagents, proceeds through a cascade process involving 1,4-hydroboration followed by transfer hydrogenation of a dihydropyridine intermediate. The retained double bond in the reduction products permits their conversion to natural products and other useful heterocyclic compounds by simple transformations.

NOVEL HYDRAZIDE CONTAINING COMPOUNDS AS BTK INHIBITORS

-

Page/Page column 55; 56, (2018/02/03)

The present invention relates to novel hydrazide containing compounds as Bruton tyrosine kinase inhibitors, process of preparation thereof, and to the use of the compounds in the preparation of pharmaceutical compositions for the therapeutic treatment of disorders involving mediation of Bruton tyrosine kinase in humans.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 27952-00-7